SCHRODER INVESTMENT MANAGEMENT GROUP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2018$316,000
-78.9%
6,562
-53.4%
0.00%
-66.7%
Q1 2018$1,496,000
+78.7%
14,077
+0.4%
0.00%
+200.0%
Q4 2017$837,000
+381.0%
14,016
+90.9%
0.00%
Q3 2017$174,000
+22.5%
7,3410.0%0.00%
Q2 2017$142,000
-58.5%
7,341
-50.0%
0.00%
Q1 2017$342,000
+280.0%
14,682
+100.0%
0.00%
Q4 2016$90,000
-28.6%
7,3410.0%0.00%
Q3 2016$126,000
+21.2%
7,3410.0%0.00%
Q2 2016$104,000
+4.0%
7,3410.0%0.00%
Q1 2016$100,000
-19.4%
7,3410.0%0.00%
Q4 2015$124,000
+55.0%
7,3410.0%0.00%
Q3 2015$80,000
-12.1%
7,3410.0%0.00%
Q2 2015$91,000
+12.3%
7,3410.0%0.00%
Q1 2015$81,000
-28.9%
7,3410.0%0.00%
Q4 2014$114,000
-100.0%
7,341
-70.4%
0.00%
Q3 2014$299,047,000
+217.8%
24,776
+237.5%
0.00%
Q2 2014$94,112,000
+5.8%
7,3410.0%0.00%
Q1 2014$88,973,000
+6.8%
7,3410.0%0.00%
Q4 2013$83,320,000
+8.7%
7,3410.0%0.00%
Q3 2013$76,677,0007,3410.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2016
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders